| Title |
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|
|---|---|
| Published in |
The Lancet, April 2020
|
| DOI | 10.1016/s0140-6736(20)31022-9 |
| Pubmed ID | |
| Authors |
Yeming Wang, Dingyu Zhang, Guanhua Du, Ronghui Du, Jianping Zhao, Yang Jin, Shouzhi Fu, Ling Gao, Zhenshun Cheng, Qiaofa Lu, Yi Hu, Guangwei Luo, Ke Wang, Yang Lu, Huadong Li, Shuzhen Wang, Shunan Ruan, Chengqing Yang, Chunlin Mei, Yi Wang, Dan Ding, Feng Wu, Xin Tang, Xianzhi Ye, Yingchun Ye, Bing Liu, Jie Yang, Wen Yin, Aili Wang, Guohui Fan, Fei Zhou, Zhibo Liu, Xiaoying Gu, Jiuyang Xu, Lianhan Shang, Yi Zhang, Lianjun Cao, Tingting Guo, Yan Wan, Hong Qin, Yushen Jiang, Thomas Jaki, Frederick G Hayden, Peter W Horby, Bin Cao, Chen Wang |
X Demographics
The data shown below were collected from the profiles of 12,761 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1415 | 11% |
| France | 1180 | 9% |
| Japan | 515 | 4% |
| Spain | 498 | 4% |
| United Kingdom | 332 | 3% |
| Canada | 224 | 2% |
| India | 189 | 1% |
| Mexico | 127 | <1% |
| Colombia | 108 | <1% |
| Other | 1544 | 12% |
| Unknown | 6629 | 52% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 11067 | 87% |
| Scientists | 777 | 6% |
| Practitioners (doctors, other healthcare professionals) | 705 | 6% |
| Science communicators (journalists, bloggers, editors) | 204 | 2% |
| Unknown | 8 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 3,485 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 3485 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 438 | 13% |
| Researcher | 393 | 11% |
| Student > Master | 317 | 9% |
| Other | 270 | 8% |
| Student > Ph. D. Student | 253 | 7% |
| Other | 652 | 19% |
| Unknown | 1162 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 905 | 26% |
| Biochemistry, Genetics and Molecular Biology | 281 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 258 | 7% |
| Agricultural and Biological Sciences | 116 | 3% |
| Nursing and Health Professions | 97 | 3% |
| Other | 520 | 15% |
| Unknown | 1308 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10874. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 April 2024.
All research outputs
#146
of 25,782,229 outputs
Outputs from The Lancet
#15
of 42,994 outputs
Outputs of similar age
#21
of 409,892 outputs
Outputs of similar age from The Lancet
#4
of 391 outputs
Altmetric has tracked 25,782,229 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 42,994 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 68.3. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 409,892 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 391 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.